share_log

海特生物:注射用艾司奥美拉唑钠获药品注册证书

wuhan hiteck biological pharma: Injection of esomeprazole sodium obtained pharmaceutical registration certificate.

Breakings ·  Sep 11 15:46

wuhan hiteck biological pharma announced that the company recently received the "Pharmaceutical registration certificate" for injection of esomeprazole sodium issued by the National Medical Products Administration. The pharmaceutical is a chemical generic drug, mainly used for the treatment of gastroesophageal reflux disease, acute gastric or duodenal ulcer bleeding, and for reducing the risk of re-bleeding after endoscopic treatment for adult gastric and duodenal ulcer bleeding.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment